Magrolimab (anti-CD47)

Magrolimab (anti-CD47) (5F9, GS-4721,Hu5F9 G4,ONO 7913) is a first-in-class macrophage immune checkpoint inhibitor that mainly binds to N-terminal pyroglutamate of CD47.
Supplier Selleck Chemicals
Product # A2036
Sku # A2036-1mg*5
Pricing 1mg*5, $857.00
Feedback